Quest Resource Holding: Sonora Quest Laboratories Announces Leadership Transition to Jennifer Erickson

Leadership Transition Signals New Era for Sonora Quest Laboratories

Sonora Quest Laboratories, a leading clinical laboratory testing provider in Arizona, announces the appointment of Jennifer Erickson as Chief Executive Officer-Elect, succeeding long-time CEO David Dexter, who plans to retire on March 31, 2026. Dexter has held the role since 1999, during which Sonora Quest has flourished, conducting over 100 million diagnostic tests annually. His leadership has been pivotal in establishing innovative initiatives, such as the direct-access testing platform, My Lab ReQuest™, launched in 2015, and the expansive COVID-19 testing framework, Operation Catapult, initiated in 2020. As the company prepares for this leadership transition, it is crucial to evaluate the impact Dexter's tenure has had on Sonora Quest's growth and the future direction under Erickson.

Erickson brings over two decades of experience in health care and consumer services, including a significant tenure as CFO of Sonora Quest from 1999 to 2004. Her comprehensive understanding of the company’s operations and strategic vision positions her well to uphold the legacy of innovation that has characterized Sonora Quest. Under Dexter’s mentorship for 26 years, Erickson has cultivated a deep connection to the company's culture, focusing on collaboration and accountability. She aims to enhance patient-centered diagnostics and fortify partnerships within the health care community, which are crucial for the company’s sustained growth in an increasingly competitive landscape.

As the new CEO prepares to step into her role, she faces the challenge of advancing the company's established initiatives while also exploring new opportunities to adapt to the evolving health care environment. Her recent position as CFO and COO at Clin-Path Associates/Pathology Specialists of Arizona further equips her with the skills to navigate the complexities of health care delivery and diagnostics. The transition marks a significant milestone for Sonora Quest, as the company looks to blend its rich legacy with innovative strategies that prioritize patient care and community engagement.

In addition to the leadership change, Sonora Quest Laboratories continues to strengthen its collaborative efforts with organizations such as the American Cancer Society and CommunityCares. These partnerships are vital in expanding access to diagnostic services and enhancing public health outcomes across Arizona. As the company embarks on this new chapter, the focus remains on leveraging technology and innovation to improve health care services for the communities it serves.